ReviewBreast cancer (Dove Medical Press)2024

Comparative Analysis and Future Prospects of Human Epidermal Growth Factor Receptor 2 (HER2) and Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted Antibody-Drug Conjugates in Breast Cancer Treatment.

Xiaojuan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.